Bone health in secondary breast cancer

Breast cancer cells can spread to the bone and weaken and damage the bone cells. As well as increasing your risk of a bone fracture (broken bone) and oesteoporosis, this can cause bone pain.

There are two types of medications that can be used to strengthen bone and treat bone pain:

  • Bisphosphonates (Zometa, Bondronat) -  given intravenously or as oral tablets
  • Biologic agents (Xgeva) - given as a monthly injection under the skin

Women with secondary breast cancer may take bisphosphonates or Xgeva to:

  • treat bone pain
  • prevent bone fractures
  • reduce the need for radiotherapy treatment of the bone cancer
  • maintain calcium levels in the blood

Side effects

Side effects of bisphosphonates and Xgeva can include:

  • diarrhoea
  • flu-like symptoms
  • nausea
  • hypocalcaemia (low levels of calcium)

There is also a very low risk of osteonecrosis (bone loss) of the jaw (ONJ).

More information

  • Read an article about bone metastases in the Autumn 2013 edition of The Inside Story (Issue 28)
  • Read an article about bisphosphonates in the Winter 2008 edition of The Inside Story (Issue 9)
  • Read an article about Xgeva in the Summer 2001 edition of The Inside Story (Issue 23)
  • Download a resource sheet to learn where to find out more about bisphosphonates

 

Hope & Hurdles

Hope & Hurdles is a free, comprehensive information resource especially  for women diagnosed with secondary breast cancer. It is also useful for family members.

You can order it online, or by phoning 1800 500 258.


Main Navigation